Insulin price cap.

Requires an insurer to cap the total amount an insured is required to pay for a 30 day supply of prescription insulin drugs at an amount not to exceed $35, regardless of the number of prescriptions and different types of insulin prescribed and filled during that period.

Voted 1/5/2026

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

Action history

1/5/2026Authored by Senator Pol
1/5/2026First reading: referred to Committee on Health and Provider Services